Change of Director’s Interest Notice Anthony John McClureNumber acquired - 600,000 @ $0.13 each. Bought on market.No. of securities held after change 3,820,752 Ordinary Shares 1,875,000 Series B $1.50 Director Options expiring 28/11/2010
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025